A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

NCT05714969 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombotic Thrombocytopenic Purpura (TTP)

Interventions

BIOLOGICAL: TAK-755

Sponsor

Takeda

Collaborators

[object Object]